Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Depei Wu

Showing results (131-140 of 579) with videos related to

Pageof 58
Sort By:
International Journal of Hematology|June 5, 2015
Prognostic impact of residual normal metaphases in acute myeloid leukemia with t(8;21)(q22;q22)Lijun Wen, Jing Xia, Qinrong Wang, et al.
Frontiers in Immunology|October 3, 2022
Case report: Rare persistent complete donor chimerism and GVHD following micro-transplantation from HLA haplotype homozygous donorsLingling Liu, Qingya Cui, Mengyun Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 16, 2016
[The role of different KIR haplotypes in haplo-identical hematopoietic stem cell transplantation]Xiaojing Bao, Jun He, Miao Wang, et al.
Frontiers in Oncology|October 28, 2021
Diagnosis and Treatment of Myeloproliferative Neoplasms With PCM1-JAK2 Rearrangement: Case Report and Literature ReviewYingxin Sun, Yifeng Cai, Jia Chen, et al.
Experimental Hematology|August 22, 2008
Establishment and characterization of a new human acute myelocytic leukemia cell line SH-2 with a loss of Y chromosome, a derivative chromosome 16 resulting from an unbalanced translocation between chromosomes 16 and 17, monosomy 17, trisomy 19, and p53 alterationHuiying Qiu, Yongquan Xue, Jun Zhang, et al.
Transplantation and Cellular Therapy|April 10, 2021
Efficiency and Toxicity of Ruxolitinib as the Salvage Treatment in Steroid-Refractory Acute Graft-Versus-Host Disease after Haplo-Identical Stem Cell TransplantationYin Liu, Yi Fan, Wenli Zhang, et al.
American Journal of Hematology|July 31, 2015
Allogeneic hematopoietic stem cell transplantation could improve survival of cytogenetically normal adult acute myeloid leukemia patients with DNMT3A mutationsYang Xu, Yanjun Sun, Hongjie Shen, et al.
Frontiers in Immunology|December 7, 2017
Inhibition of Acute Graft-versus-Host Disease with Retention of Graft-versus-Tumor Effects by Dimethyl FumarateJingjing Han, Shoubao Ma, Huanle Gong, et al.
Science China. Life Sciences|August 18, 2019
Comparison of the clinical outcomes of hematologic malignancies after myeloablative haploidentical transplantation with G-CSF/ATG and posttransplant cyclophosphamide: results from the Chinese Bone Marrow Transplantation Registry Group (CBMTRG)Feifei Tang, Yajing Xu, Huiren Chen, et al.
Frontiers in Oncology|March 10, 2025
Exploration of risk factors and characteristics of COVID-19 infection among patients with hematological malignancies in Suzhou, China: a retrospective studyYao Yao, Wenjuan Di, Fangkai He, et al.
Pageof 58

Showing results (131-140 of 579) with videos related to

Sort By:
Pageof 58
International Journal of Hematology|June 5, 2015
Prognostic impact of residual normal metaphases in acute myeloid leukemia with t(8;21)(q22;q22)Lijun Wen, Jing Xia, Qinrong Wang, et al.
Frontiers in Immunology|October 3, 2022
Case report: Rare persistent complete donor chimerism and GVHD following micro-transplantation from HLA haplotype homozygous donorsLingling Liu, Qingya Cui, Mengyun Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 16, 2016
[The role of different KIR haplotypes in haplo-identical hematopoietic stem cell transplantation]Xiaojing Bao, Jun He, Miao Wang, et al.
Frontiers in Oncology|October 28, 2021
Diagnosis and Treatment of Myeloproliferative Neoplasms With PCM1-JAK2 Rearrangement: Case Report and Literature ReviewYingxin Sun, Yifeng Cai, Jia Chen, et al.
Experimental Hematology|August 22, 2008
Establishment and characterization of a new human acute myelocytic leukemia cell line SH-2 with a loss of Y chromosome, a derivative chromosome 16 resulting from an unbalanced translocation between chromosomes 16 and 17, monosomy 17, trisomy 19, and p53 alterationHuiying Qiu, Yongquan Xue, Jun Zhang, et al.
Transplantation and Cellular Therapy|April 10, 2021
Efficiency and Toxicity of Ruxolitinib as the Salvage Treatment in Steroid-Refractory Acute Graft-Versus-Host Disease after Haplo-Identical Stem Cell TransplantationYin Liu, Yi Fan, Wenli Zhang, et al.
American Journal of Hematology|July 31, 2015
Allogeneic hematopoietic stem cell transplantation could improve survival of cytogenetically normal adult acute myeloid leukemia patients with DNMT3A mutationsYang Xu, Yanjun Sun, Hongjie Shen, et al.
Frontiers in Immunology|December 7, 2017
Inhibition of Acute Graft-versus-Host Disease with Retention of Graft-versus-Tumor Effects by Dimethyl FumarateJingjing Han, Shoubao Ma, Huanle Gong, et al.
Science China. Life Sciences|August 18, 2019
Comparison of the clinical outcomes of hematologic malignancies after myeloablative haploidentical transplantation with G-CSF/ATG and posttransplant cyclophosphamide: results from the Chinese Bone Marrow Transplantation Registry Group (CBMTRG)Feifei Tang, Yajing Xu, Huiren Chen, et al.
Frontiers in Oncology|March 10, 2025
Exploration of risk factors and characteristics of COVID-19 infection among patients with hematological malignancies in Suzhou, China: a retrospective studyYao Yao, Wenjuan Di, Fangkai He, et al.
Pageof 58